Cargando…
Lung Cancer Screening: Review and 2021 Update
PURPOSE OF REVIEW: Lung cancer screening with low-dose CT (LDCT) scans has been widely accepted within the last decade. Our knowledge and ability to implement screening has greatly increased because of significant research efforts and guidelines from multiple professional societies. The purpose of t...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976270/ https://www.ncbi.nlm.nih.gov/pubmed/35402145 http://dx.doi.org/10.1007/s13665-021-00283-1 |
_version_ | 1784680530950750208 |
---|---|
author | Ramaswamy, Anuradha |
author_facet | Ramaswamy, Anuradha |
author_sort | Ramaswamy, Anuradha |
collection | PubMed |
description | PURPOSE OF REVIEW: Lung cancer screening with low-dose CT (LDCT) scans has been widely accepted within the last decade. Our knowledge and ability to implement screening has greatly increased because of significant research efforts and guidelines from multiple professional societies. The purpose of this review is to summarize some of the significant findings pertaining to lung cancer screening. RECENT FINDINGS: Screening with LDCT decreases lung cancer mortality in multiple studies. Use of validated risk prediction calculators can improve patient selection and screening efficiency. Shared decision making and smoking cessation counseling are essential screening components. Multidisciplinary involvement is required for the success of a screening program. SUMMARY: Lung cancer screening is complex, and implementation of a successful program requires multidisciplinary expertise. Further prospective studies are required to determine optimal patient selection, screening intervals, and strategies to maximize benefit while further decreasing harms.’ |
format | Online Article Text |
id | pubmed-8976270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-89762702022-04-04 Lung Cancer Screening: Review and 2021 Update Ramaswamy, Anuradha Curr Pulmonol Rep Interventional Pulmonology (G Cheng, Section Editor) PURPOSE OF REVIEW: Lung cancer screening with low-dose CT (LDCT) scans has been widely accepted within the last decade. Our knowledge and ability to implement screening has greatly increased because of significant research efforts and guidelines from multiple professional societies. The purpose of this review is to summarize some of the significant findings pertaining to lung cancer screening. RECENT FINDINGS: Screening with LDCT decreases lung cancer mortality in multiple studies. Use of validated risk prediction calculators can improve patient selection and screening efficiency. Shared decision making and smoking cessation counseling are essential screening components. Multidisciplinary involvement is required for the success of a screening program. SUMMARY: Lung cancer screening is complex, and implementation of a successful program requires multidisciplinary expertise. Further prospective studies are required to determine optimal patient selection, screening intervals, and strategies to maximize benefit while further decreasing harms.’ Springer US 2022-04-02 2022 /pmc/articles/PMC8976270/ /pubmed/35402145 http://dx.doi.org/10.1007/s13665-021-00283-1 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Interventional Pulmonology (G Cheng, Section Editor) Ramaswamy, Anuradha Lung Cancer Screening: Review and 2021 Update |
title | Lung Cancer Screening: Review and 2021 Update |
title_full | Lung Cancer Screening: Review and 2021 Update |
title_fullStr | Lung Cancer Screening: Review and 2021 Update |
title_full_unstemmed | Lung Cancer Screening: Review and 2021 Update |
title_short | Lung Cancer Screening: Review and 2021 Update |
title_sort | lung cancer screening: review and 2021 update |
topic | Interventional Pulmonology (G Cheng, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976270/ https://www.ncbi.nlm.nih.gov/pubmed/35402145 http://dx.doi.org/10.1007/s13665-021-00283-1 |
work_keys_str_mv | AT ramaswamyanuradha lungcancerscreeningreviewand2021update |